NO20005313L - Perforale sammensetninger av levosimendan med kontrollert frigjöring - Google Patents

Perforale sammensetninger av levosimendan med kontrollert frigjöring

Info

Publication number
NO20005313L
NO20005313L NO20005313A NO20005313A NO20005313L NO 20005313 L NO20005313 L NO 20005313L NO 20005313 A NO20005313 A NO 20005313A NO 20005313 A NO20005313 A NO 20005313A NO 20005313 L NO20005313 L NO 20005313L
Authority
NO
Norway
Prior art keywords
perforated
compositions
controlled release
levosimendan
release levosimendan
Prior art date
Application number
NO20005313A
Other languages
English (en)
Other versions
NO329809B1 (no
NO20005313D0 (no
Inventor
Ilkka Larma
Maarit Baeckman
Saila Antila
Lasse Lehtonen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8551575&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005313(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20005313D0 publication Critical patent/NO20005313D0/no
Publication of NO20005313L publication Critical patent/NO20005313L/no
Publication of NO329809B1 publication Critical patent/NO329809B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
NO20005313A 1998-04-23 2000-10-20 Perorale sammensetninger av levosimendan med kontrollert frigjoring NO329809B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980901A FI980901A (fi) 1998-04-23 1998-04-23 Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
PCT/FI1999/000329 WO1999055305A2 (en) 1998-04-23 1999-04-23 Controlled release peroral compositions of levosimendan

Publications (3)

Publication Number Publication Date
NO20005313D0 NO20005313D0 (no) 2000-10-20
NO20005313L true NO20005313L (no) 2000-11-21
NO329809B1 NO329809B1 (no) 2010-12-20

Family

ID=8551575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005313A NO329809B1 (no) 1998-04-23 2000-10-20 Perorale sammensetninger av levosimendan med kontrollert frigjoring

Country Status (38)

Country Link
US (1) US7045147B1 (no)
EP (1) EP1071397B1 (no)
JP (2) JP4566402B2 (no)
KR (1) KR100960597B1 (no)
CN (1) CN1248691C (no)
AR (1) AR019096A1 (no)
AT (1) ATE258425T1 (no)
AU (1) AU756641B2 (no)
BG (1) BG64839B1 (no)
BR (1) BR9909869A (no)
CA (1) CA2329234C (no)
CO (1) CO5070607A1 (no)
CZ (1) CZ295194B6 (no)
DE (1) DE69914472T2 (no)
DK (1) DK1071397T3 (no)
EA (1) EA002829B1 (no)
EE (1) EE04220B1 (no)
ES (1) ES2215379T3 (no)
FI (1) FI980901A (no)
GE (1) GEP20032906B (no)
HK (1) HK1034032A1 (no)
HR (1) HRP20000704B1 (no)
HU (1) HUP0101458A3 (no)
ID (1) ID27987A (no)
IL (2) IL138951A0 (no)
MX (1) MXPA00010367A (no)
NO (1) NO329809B1 (no)
NZ (1) NZ507453A (no)
PL (1) PL197447B1 (no)
PT (1) PT1071397E (no)
RS (1) RS49962B (no)
SI (1) SI1071397T1 (no)
SK (1) SK285427B6 (no)
TR (1) TR200003102T2 (no)
TW (1) TWI224507B (no)
UA (1) UA68376C2 (no)
WO (1) WO1999055305A2 (no)
ZA (1) ZA200005632B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
JP2006520390A (ja) * 2003-03-14 2006-09-07 ムルイェ、ニルマル 徐放性錠剤の製造方法
FI20070521L (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
CA2724740C (en) 2008-06-30 2017-02-21 Tocagen Inc. Formulations of 5-fluorocytosine and uses thereof
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ203684A (en) 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578A (fi) * 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia

Also Published As

Publication number Publication date
SI1071397T1 (en) 2004-06-30
HRP20000704B1 (en) 2009-11-30
EA002829B1 (ru) 2002-10-31
FI980901A (fi) 1999-10-24
SK285427B6 (sk) 2007-01-04
CZ295194B6 (cs) 2005-06-15
EE04220B1 (et) 2004-02-16
HK1034032A1 (en) 2001-10-12
PT1071397E (pt) 2004-06-30
WO1999055305A3 (en) 1999-12-29
NZ507453A (en) 2003-02-28
ZA200005632B (en) 2002-01-14
SK15542000A3 (sk) 2001-08-06
BR9909869A (pt) 2000-12-19
US7045147B1 (en) 2006-05-16
DE69914472D1 (de) 2004-03-04
DK1071397T3 (da) 2004-04-05
JP2010083900A (ja) 2010-04-15
KR20010071172A (ko) 2001-07-28
BG104959A (en) 2001-07-31
TWI224507B (en) 2004-12-01
ID27987A (id) 2001-05-03
FI980901A0 (fi) 1998-04-23
CA2329234A1 (en) 1999-11-04
HRP20000704A2 (en) 2001-04-30
RS49962B (sr) 2008-09-29
GEP20032906B (en) 2003-02-25
YU63900A (sh) 2003-07-07
WO1999055305A2 (en) 1999-11-04
PL344078A1 (en) 2001-09-24
CN1248691C (zh) 2006-04-05
AR019096A1 (es) 2001-12-26
BG64839B1 (bg) 2006-06-30
EA200001098A1 (ru) 2001-04-23
CO5070607A1 (es) 2001-08-28
AU3524699A (en) 1999-11-16
EP1071397B1 (en) 2004-01-28
AU756641B2 (en) 2003-01-16
TR200003102T2 (tr) 2001-02-21
CZ20003780A3 (en) 2001-05-16
EE200000617A (et) 2002-06-17
IL138951A0 (en) 2001-11-25
DE69914472T2 (de) 2004-11-11
MXPA00010367A (es) 2002-06-04
KR100960597B1 (ko) 2010-06-07
PL197447B1 (pl) 2008-03-31
EP1071397A2 (en) 2001-01-31
CN1301163A (zh) 2001-06-27
CA2329234C (en) 2008-06-10
UA68376C2 (en) 2004-08-16
HUP0101458A2 (hu) 2002-03-28
JP2002512946A (ja) 2002-05-08
HUP0101458A3 (en) 2002-05-28
ES2215379T3 (es) 2004-10-01
IL138951A (en) 2006-10-31
JP4566402B2 (ja) 2010-10-20
NO329809B1 (no) 2010-12-20
ATE258425T1 (de) 2004-02-15
NO20005313D0 (no) 2000-10-20

Similar Documents

Publication Publication Date Title
NO20012857D0 (no) Galantaminsammensetning med kontrollert frigivelse
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
DK0758244T3 (da) Doseringsformer af azithromycin med styret frigivelse
DK1126826T3 (da) Multipartikel-modificeret-frigivelsessammensætning af methylphenidat
DK0954966T3 (da) Polymere sammensætninger med reguleret frigivelse
AR027907A1 (es) Composicion de liberacion controlada
PT945132E (pt) Composicao de ibuprofeno
NO995852D0 (no) Ny form av S-omeprazol
NO20021540D0 (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
DE59706557D1 (de) Keramische Auskleidung
NO20001585D0 (no) Orale sammensetninger av levosimendan
NO994790L (no) Estimering av permabilitet
IS4398A (is) Ný lyfjablanda til inntöku um munn sem inniheldurmagnesíumsalt af ómeprasóli
DE59706558D1 (de) Keramische Auskleidung
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
NO20014301D0 (no) Sammensetninger med kontrollert frigivelse av betahistin
NO20005313L (no) Perforale sammensetninger av levosimendan med kontrollert frigjöring
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
IS5821A (is) Kristalluð form af ósanetant
NO20004583D0 (no) Krystallinsk form av paroxetine
GC0000104A (en) Controlled release peroral compositions of levosimendan.
DK0949237T3 (da) Fremgangsmåde til fremstilling af dihydrocitral
DK1133290T3 (da) Anvendelse af acetylcholinesterase-inhibitorer til behandling af delirier

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees